Hydronorm-200 (Hydroxychloroquine Sulphate Tablets IP) is a trusted formulation developed by Ennromed Pharma, Panchkula, India, for the prevention and treatment of malaria and autoimmune conditions such as rheumatoid arthritis and lupus erythematosus.

Produced in a GMP and ISO-certified manufacturing facility, Hydronorm-200 is known for its precise dosage accuracy, purity, and stability. It meets stringent global regulatory requirements, making it a preferred product for pharmaceutical distributors, government tenders, and international buyers across Africa, Asia, and Latin America.

With consistent global demand and trusted formulation standards, Hydronorm-200 reinforces Ennromed Pharma’s reputation as a leading hydroxychloroquine manufacturer and exporter from India.

⚙️ Key Features & Benefits

• 💠 Composition: Hydroxychloroquine Sulphate IP 200 mg

• 🏭 Manufactured in WHO-GMP & ISO-certified facilities

• 🌍 Export-ready product complying with international pharmacopeia standards

• 💊 Effective for malaria prophylaxis and autoimmune disorders

• 📦 Available in 10 × 10 tablet blister packs for ease of distribution

• 🧪 High bioavailability and long shelf life

• 🔒 Secure, tamper-evident packaging

📦 Packaging Information

• Brand Name: Hydronorm-200

• Composition: Hydroxychloroquine Sulphate IP 200 mg

• Packaging Size: 10 × 10 Tablets (100 tablets per box)

• Manufacturer: Ennromed Pharma, Panchkula (India)

• Certification: WHO-GMP, ISO 9001:2015

• Shelf Life: 24 months (standard storage conditions)

⚠️ Disclaimer

This product is intended strictly for export, prescription, and authorised medical use under applicable health regulations. Ennromed Pharma does not promote self-medication or misuse of pharmaceutical products.